Oxygen metabolites stimulate mucous glycoprotein secretion from cultured rat gastric mucous cells. 1991

H Hiraishi, and A Terano, and S Ota, and H Mutoh, and T Sugimoto, and M Razandi, and K J Ivey
Department of Medicine, Veterans Affairs Medical Center, Long Beach 90822.

The aims of this study were to investigate the interaction between oxygen radicals and mucus secretion from cultured rat gastric mucous cells, and to assess the role of prostaglandin production in the modulation of mucus secretion in vitro. Xanthine oxidase in the presence of hypoxanthine caused a dose-dependent increase in the presence of hypoxanthine caused a dose-dependent increase of mucus secretion, as assessed by release of [3H]glucosamine from prelabeled cells, whereas xanthine oxidase or hypoxanthine alone did not. Xanthine oxidase (10 mU/ml) increased release of [3H]glucosamine by 57 +/- 6% compared with control values (P less than 0.001). Catalase (3,000 U/ml) inhibited xanthine oxidase-induced mucus secretion by 69 +/- 9% (P less than 0.01), whereas superoxide dismutase did not. Pretreatment with deferoxamine, an inhibitor of hydroxyl radical generation through chelating ferric ion, diminished oxygen radical-induced mucus release to control values. Xanthine oxidase dose dependently stimulated prostaglandin E2 (PGE2) production, which was blocked by catalase but not by superoxide dismutase. However, oxygen radical stimulation of mucus secretion was not inhibited by the addition of indomethacin. Moreover, PGE2, exogenously administered, did not significantly accelerate mucus secretion. Stimulation of mucus secretion by oxygen radicals was not accompanied by increased 51Cr release or by leakage of intracellular lactate dehydrogenase. These results suggest that oxygen species, particularly hydroxyl radical, stimulate mucous glycoprotein secretion from cultured rat gastric mucous cells. However, it seems unlikely that prostaglandin production mediates the oxygen species-induced stimulation of mucus secretion.

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D007770 L-Lactate Dehydrogenase A tetrameric enzyme that, along with the coenzyme NAD+, catalyzes the interconversion of LACTATE and PYRUVATE. In vertebrates, genes for three different subunits (LDH-A, LDH-B and LDH-C) exist. Lactate Dehydrogenase,Dehydrogenase, L-Lactate,Dehydrogenase, Lactate,L Lactate Dehydrogenase
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D002374 Catalase An oxidoreductase that catalyzes the conversion of HYDROGEN PEROXIDE to water and oxygen. It is present in many animal cells. A deficiency of this enzyme results in ACATALASIA. Catalase A,Catalase T,Manganese Catalase,Mn Catalase
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003676 Deferoxamine Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form. Desferrioxamine,Deferoxamine B,Deferoxamine Mesilate,Deferoxamine Mesylate,Deferoxamine Methanesulfonate,Deferoximine,Deferrioxamine B,Desferal,Desferioximine,Desferrioxamine B,Desferrioxamine B Mesylate,Desferroxamine,Mesilate, Deferoxamine,Mesylate, Deferoxamine,Mesylate, Desferrioxamine B,Methanesulfonate, Deferoxamine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005609 Free Radicals Highly reactive molecules with an unsatisfied electron valence pair. Free radicals are produced in both normal and pathological processes. Free radicals include reactive oxygen and nitrogen species (RONS). They are proven or suspected agents of tissue damage in a wide variety of circumstances including radiation, damage from environment chemicals, and aging. Natural and pharmacological prevention of free radical damage is being actively investigated. Free Radical
D005753 Gastric Mucosa Lining of the STOMACH, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. The surface cells produce MUCUS that protects the stomach from attack by digestive acid and enzymes. When the epithelium invaginates into the LAMINA PROPRIA at various region of the stomach (CARDIA; GASTRIC FUNDUS; and PYLORUS), different tubular gastric glands are formed. These glands consist of cells that secrete mucus, enzymes, HYDROCHLORIC ACID, or hormones. Cardiac Glands,Gastric Glands,Pyloric Glands,Cardiac Gland,Gastric Gland,Gastric Mucosas,Gland, Cardiac,Gland, Gastric,Gland, Pyloric,Glands, Cardiac,Glands, Gastric,Glands, Pyloric,Mucosa, Gastric,Mucosas, Gastric,Pyloric Gland

Related Publications

H Hiraishi, and A Terano, and S Ota, and H Mutoh, and T Sugimoto, and M Razandi, and K J Ivey
September 1994, The Journal of laboratory and clinical medicine,
H Hiraishi, and A Terano, and S Ota, and H Mutoh, and T Sugimoto, and M Razandi, and K J Ivey
January 1989, Symposia of the Society for Experimental Biology,
H Hiraishi, and A Terano, and S Ota, and H Mutoh, and T Sugimoto, and M Razandi, and K J Ivey
August 1989, Chemical & pharmaceutical bulletin,
H Hiraishi, and A Terano, and S Ota, and H Mutoh, and T Sugimoto, and M Razandi, and K J Ivey
May 1997, Biological & pharmaceutical bulletin,
H Hiraishi, and A Terano, and S Ota, and H Mutoh, and T Sugimoto, and M Razandi, and K J Ivey
November 1995, European journal of gastroenterology & hepatology,
H Hiraishi, and A Terano, and S Ota, and H Mutoh, and T Sugimoto, and M Razandi, and K J Ivey
March 1985, In vitro cellular & developmental biology : journal of the Tissue Culture Association,
H Hiraishi, and A Terano, and S Ota, and H Mutoh, and T Sugimoto, and M Razandi, and K J Ivey
November 2004, Life sciences,
H Hiraishi, and A Terano, and S Ota, and H Mutoh, and T Sugimoto, and M Razandi, and K J Ivey
October 1994, Biological & pharmaceutical bulletin,
H Hiraishi, and A Terano, and S Ota, and H Mutoh, and T Sugimoto, and M Razandi, and K J Ivey
July 1983, Endocrinology,
H Hiraishi, and A Terano, and S Ota, and H Mutoh, and T Sugimoto, and M Razandi, and K J Ivey
August 1983, Biochemical and biophysical research communications,
Copied contents to your clipboard!